Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase

TAI-CHUNG TSENGHosaka, TetsuyaTetsuyaHosakaCHUN-JEN LIUSuzuki, FumitakaFumitakaSuzukiCHUN-MING HONGKumada, HiromitsuHiromitsuKumadaYang, Wan-TingWan-TingYangHsu, Chen-YangChen-YangHsuTUNG-HUNG SUHUNG-CHIH YANGCHEN-HUA LIUPEI-JER CHENHSIU-HSI CHENJIA-HORNG KAO2022-09-292022-09-292022-05-010002-9270https://scholars.lib.ntu.edu.tw/handle/123456789/623259Many patients with chronic hepatitis B (CHB) are classified as indeterminate patients because they fall outside the defined CHB phases. We aimed to explore hepatocellular carcinoma (HCC) risk in hepatitis B e antigen (HBeAg)-negative patients with indeterminate phase and investigated whether the risk could be stratified by serum levels of hepatitis B core-related antigen (HBcrAg).enSURFACE-ANTIGEN; HEPATOCELLULAR-CARCINOMA; DISEASE PROGRESSION[SDGs]SDG3Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phasejournal article10.14309/ajg.0000000000001691351913992-s2.0-85128476921WOS:000789692700018